These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7138756)

  • 1. Effect of labetalol, an alpha-and beta-adrenoceptor antagonist, on gastric acid and gastrin secretion in man.
    Caldara R; Rampini P; Piepoli V; Borzoi M
    Br J Clin Pharmacol; 1982 Nov; 14(5):744-6. PubMed ID: 7138756
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of labetalol, an alpha- & beta-adrenoceptor blocking agent on gastric acid secretion & gastric ulcers in pylorus-ligated rats.
    Sharma HK; Khanna NK; Vyas DS; Singhal BD
    Indian J Exp Biol; 1978 Oct; 16(10):1093-4. PubMed ID: 750394
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of a beta 2-sympathomimetic on gastrin release, acid secretion, and blood glucose during basal conditions and in response to insulin, 2-deoxy-D-glucose, and feeding in the dog.
    Gottrup F; Løvgreen NA; Andersen D
    Scand J Gastroenterol; 1981; 16(5):673-80. PubMed ID: 7034159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bombesin-stimulated gastrin on gastric acid secretion in man.
    Delle Fave G; Kohn A; de Magistris L; Mancuso M; Sparvoli C
    Life Sci; 1980 Sep; 27(11):993-9. PubMed ID: 7432100
    [No Abstract]   [Full Text] [Related]  

  • 5. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.
    Brittain RT; Drew GM; Levy GP
    Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of potassium chloride on gastric acid secretion and gastrin release in humans.
    Feldman M; Goldschmiedt M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):407-14. PubMed ID: 1420734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic control of gastric acid and gastrin secretion in man: lack of effects after acute oral administration of ibopamine, an analogue of dopamine.
    Caldara R; Masci E; Barbieri C; Cambielli M; Ferrari C; Tittobello A
    Br J Clin Pharmacol; 1983 Jul; 16(1):112-4. PubMed ID: 6882619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of temperature on the alpha-adrenoceptor antagonist potency of indoramin and labetalol in the rat perfused mesenteric vascular bed.
    McAdams RP
    J Pharm Pharmacol; 1984 Sep; 36(9):628-9. PubMed ID: 6149291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropharmacological actions of labetalol.
    Dadhich AP; Khanna NK; Vyas DS; Jain P
    Indian J Physiol Pharmacol; 1979; 23(1):39-43. PubMed ID: 437873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the rate and force responses to phenylephrine on rat atria with labetalol.
    Simpson WW; McNeill JH
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):373-6. PubMed ID: 7414055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha- and beta-adrenoceptor blockade by labetalol in human isolated arteries and veins.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1980 Jun; 9(6):621-3. PubMed ID: 6104500
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
    Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
    Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a regulatory role of alpha-2 receptors on gastric acid secretion and gastrin release in the dog.
    Mengozzi G; Della Longa A; Martelli F; Soldani G
    Pharmacol Res Commun; 1988 May; 20(5):425-6. PubMed ID: 2901757
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nifedipine on gastric acid secretion and gastrin release in man.
    McColl KE; Buchanan NM; Laferla G; Hearns J; Buchanan K; Crean GP
    Gut; 1987 Apr; 28(4):455-9. PubMed ID: 3556337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.